These results strongly suggest that curcumin nanoformulations, particularly PFZ and CFZ, substantially promote remyelination following CPZ-induced demyelination, outperforming the natural recovery observed in the CPZ-only group. The gene discussed is CPZ; the disease is Peripheral demyelination.